glp 1 agonist pcos GLP-1 agonists and weight Loss GLP-1 receptor agonists versus metformin

Licensed healthcare professionals develop personalized care plans that take into account PCOS-specific issues such as hormonal imbalances, irregular menstrual cycles, and insulin resistance

unforeseen episodes of hypoglycemia from a loss of glucagon

Thus, new anti-obesity treatments are needed

The 28.7% average weight loss at 68 weeks exceeds every other compound that has been tested in rigorous clinical trials

Diabetes Obes Metab 26: 54745478

Upon activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), berberine enhances insulin sensitivity, reduces hepatic glucose output, and has been shown in animal models to increase GLP-1 secretion, although this mechanism has not yet been confirmed in large human trials